×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ELDN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/19
05:59 pm
eldn
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results [Yahoo! Finance]
3/19
05:10 pm
eldn
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
Low
Report
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
3/16
04:51 pm
eldn
Eledon sees promising data for tegoprubart in islet transplant type 1 diabetes. [Seeking Alpha]
Medium
Report
Eledon sees promising data for tegoprubart in islet transplant type 1 diabetes. [Seeking Alpha]
3/16
01:48 pm
eldn
Eledon Pharmaceuticals: Tegoprubart Continues To Shine As Immunosuppressive Alternative [Seeking Alpha]
Neutral
Report
Eledon Pharmaceuticals: Tegoprubart Continues To Shine As Immunosuppressive Alternative [Seeking Alpha]
3/16
07:08 am
eldn
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine [Yahoo! Finance]
Low
Report
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine [Yahoo! Finance]
3/16
07:00 am
eldn
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
Low
Report
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
3/15
02:52 pm
eldn
Eledon Pharmaceuticals Touts Tegoprubart Safety in BESTOW Kidney Transplant Data at Leerink Conference [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals Touts Tegoprubart Safety in BESTOW Kidney Transplant Data at Leerink Conference [Yahoo! Finance]
3/10
07:37 am
eldn
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation [Yahoo! Finance]
Medium
Report
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/19/2026
05:10 pm
ELDN
eledon pharmaceuticals, inc.
MISS
Report
-2.7%
eledon pharmaceuticals, inc.
11/14/2025
05:00 pm
ELDN
eledon pharmaceuticals, inc.
BEAT
Report
-7.0%
eledon pharmaceuticals, inc.
8/14/2025
04:20 pm
ELDN
eledon pharmaceuticals, inc.
BEAT
Report
1.2%
eledon pharmaceuticals, inc.
5/14/2025
04:01 pm
ELDN
eledon pharmaceuticals, inc.
BEAT
Report
2.1%
eledon pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/26
06:03 pm
eldn
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: VANGUARD GROUP INC
3/19
05:06 pm
eldn
Form 10-K Eledon Pharmaceuticals, For: Dec 31
Low
Report
Form 10-K Eledon Pharmaceuticals, For: Dec 31
3/19
05:02 pm
eldn
Form 8-K Eledon Pharmaceuticals, For: Mar 19
Low
Report
Form 8-K Eledon Pharmaceuticals, For: Mar 19
2/17
04:29 pm
eldn
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
2/13
04:15 pm
eldn
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: Coastlands Capital LP
Low
Report
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: Coastlands Capital LP
1/21
12:32 pm
eldn
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: BlackRock, Inc.
Medium
Report
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: BlackRock, Inc.
1/16
05:00 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: McBride John S.
Medium
Report
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: McBride John S.
1/16
05:00 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Katkin Keith
Medium
Report
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Katkin Keith
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: